Weber Inc. WEBR 深 滬
等待開盤 08-21 09:30:00 美东时间
8.12
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 8.12
- 總市值 43.64万
- 52周最高 12.25
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.82
- 委 比 0.00%
- 總股本 5.37万
- 歷史最高 20.32
- 量 比 0
- 振 幅 0.00%
- 歷史最低 4.82
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Architectural billings slump persists as smaller construction projects face pressure
U.S. architectural billings weakened in July, signaling continued pressure on nonresidential construction activity over the next nine to 12 months, according to BNP Paribas Equity Research senior anal...
08-20 23:12
EquipmentShare (EQPT) 2026财年第二季度业绩电话会议：租赁收入大增39%
EquipmentShare 2026年第二季度营收增长26%至14亿美元，其中租赁收入增长超39%。管理层认为，定价和设备消化率将对下半年业绩形成支撑。
08-14 11:32
Tango Therapeutics Announces Executive Chair Barbara Weber’s Departure
Tango Therapeutics ( ($TNGX) ) has shared an update. Tango Therapeutics disclos...
08-07 06:23
Tango Therapeutics Announces Executive Chair Transition
Tango Therapeutics announced that Dr. Barbara Weber, its Executive Chairman, will step down due to other pursuits. Dr. Weber expressed pride in the company's achievements and confidence in its future. Tango President Dr. Malte Peters thanked Dr. Weber for her vision, leadership, and commitment. Tango Therapeutics is a clinical-stage biotech company focused on developing precision cancer medicines using synthetic lethality to target critical cance...
08-06 22:24
Vivoryon Therapeutics N.V. Reports H1 2026 Financial Results and Provides Business Update
Vivoryon Therapeutics N.V. reported its H1 2026 financial results, highlighting strategic progress in licensing negotiations, deeper insights into varoglutamstat's mechanism in kidney disease, and maintained financial guidance with cash sufficient until Q4 2026. The company also announced a conference call to discuss results.
08-06 05:00
SA analyst upgrades/downgrades: AAPL, PLTR, SNDK, AMZN
Recent analyst actions from Seeking Alpha contributors feature notable upgrades for Sandisk Corporation (SNDK) and Palantir Technologies (PLTR), both driven by strong AI-related catalysts and impressi...
08-06 02:02
NW Natural Holdings 2026年第二季度财报：营收增长3.1%，转为小幅盈利
NW Natural Holdings 2026年第二季度营收2.436亿美元，同比增长3.1%；稀释EPS由-0.06美元升至0.01美元，净利润60万美元。公司预计全年EPS处于2.95至3.15美元指引区间上半部。
08-05 10:17
ADM 2026年第二季度财报：调整后EPS近翻倍并上调全年指引
ADM（ADM）2026年第二季度GAAP稀释EPS为1.87美元，调整后EPS为1.84美元、同比增长98%；分部营业利润增75%至14.5亿美元，全年调整后EPS指引上调至5.15至5.60美元。
08-05 06:25
Nature’s Sunshine Appoints Janine Weber as Executive Vice President and President, North America
Nature’s Sunshine Products announced the appointment of Janine Weber as Executive Vice President and President, North America, effective August 10, 2026. With over 25 years of leadership experience in direct selling, sales, and business development, Weber will oversee North America operations, focusing on growth, consultant engagement, and customer experience. Weber previously served as Regional President at LifeWave and held senior roles at Roda...
08-03 17:45
First Western Trust Rings the Nasdaq Closing Bell Ahead of 25 Years of Serving Wealth Creators
Denver-based First Western Trust, a private bank and trust company, celebrated its 25th anniversary and recognition as one of Colorado's last locally headquartered, publicly traded banks. The company marked this milestone by ringing the Nasdaq Closing Bell in Times Square, showcasing its growth and commitment to serving wealth creators in the West. Since going public in 2019, First Western Trust has tripled its assets and doubled its locations, e...
07-30 16:28
